Patents by Inventor Perry F. Bartlett

Perry F. Bartlett has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of treatment
    Patent number: 7897570
    Abstract: The present invention relates generally to a method of treatment and in particular a method of treating disorders of the nervous system such as arising from or during disease or injury. The method of the present invention involves manipulating expression of Eph receptors or their functional equivalents to increase or decrease expression or function depending on the condition being treated.
    Type: Grant
    Filed: January 14, 2008
    Date of Patent: March 1, 2011
    Assignees: The Walter and Eliza Hall Institute of Medical Research, The Council of the Queensland Institute of Medical Research, The University of Melbourne
    Inventors: Perry F. Bartlett, Lynne Hartley, Mark Pouzzotto, Trevor Kilpatrick, Frank Kontgen, Jason Coonan, Ursula Greferath, Andrew W. Boyd, Mirella Dottori, Mary P. Galea, George Paxinos, Mark Murphy
  • Treating Gliosis, Glial Scarring, Inflammation or Inhibition of Axonal Growth in the Nervous System by Modulating Eph Receptor
    Publication number: 20080254023
    Abstract: The present invention relates to a method of treating disorders of the nervous system and more particularly disorders associated with a gliotic response and/or an inflammatory response within the central nervous system and to therapeutic agents useful for same. More particularly, the present invention involves a method of preventing or reducing the amount of Eph receptor-mediated gliosis and/or glial scarring and/or inflammation and/or Eph receptor-mediated inhibition of axonal growth which occurs during and/or after disease or injury to the nervous system. The present invention also facilitates the identification of therapeutic agents which modulate Eph receptor-mediated signaling. The method and therapeutic agents of the present invention are useful for treating a range of nervous system diseases, conditions and injuries including, inter alia, paralysis induced by physiological-, pathological- or trauma-induced injury to the brain or spinal cord.
    Type: Application
    Filed: September 8, 2005
    Publication date: October 16, 2008
    Applicants: THE UNIVERSITY OF QUEENSLAND, THE UNIVERSITY OF MELBOURNE
    Inventors: Perry F. Bartlett, Mary P. Galea, Yona Goldsmith, Ann M. Turnley, Andrew W. Boyd
  • Method of treatment
    Publication number: 20080255044
    Abstract: The present invention relates generally to a method of treatment and in particular a method of treating disorders of the nervous system such as arising from or during disease or injury. The method of the present invention involves manipulating expression of Eph receptors or their functional equivalents to increase or decrease expression or function depending on the condition being treated.
    Type: Application
    Filed: January 14, 2008
    Publication date: October 16, 2008
    Inventors: Perry F. Bartlett, Lynne Hartley, Mark Pouzzotto, Trevor Kilpatrick, Frank Kontgen, Jason Coonan, Ursula Greferath, Andrew W. Boyd, Mirella Dottori, Mary P. Galea, George Paxinos, Mark Murphy
  • Method of treatment
    Patent number: 7341997
    Abstract: The present invention relates generally to a method of treatment and in particular a method of treating disorders of the nervous system such as arising from or during disease or injury. The method of the present invention involves manipulating expression of Eph receptors or their functional equivalents to increase or decrease expression or function depending on the condition being treated.
    Type: Grant
    Filed: April 7, 2005
    Date of Patent: March 11, 2008
    Assignees: The Walter and Eliza Hall Institute of Medical Research, The Council of the Queensland Institute of Medical Research, The University of Melbourne
    Inventors: Perry F. Bartlett, Lynne Hartley, Mark Pouzzotto, Trevor Kilpatrick, Frank Kontgen, Jason Coonan, Ursula Greferath, Andrew W. Boyd, Mirella Dottori, Mary P. Galea, George Paxinos, Mark Murphy
  • Biologically active complex of NR6 and cardiotrophin-like-cytokine
    Patent number: 7192576
    Abstract: The present invention relates generally to a biologically active complex comprising at least two heterologous molecules. More particularly, the biologically active complex of the present invention comprises at least two polypeptides or parts, fragments, truncates or protease-activated forms of one or more of the polypeptides wherein the complex alone or in association with a receptor, ligand or other molecule facilitates proliferation, differentiation and/or survival of a cell. The identification of the biologically active complex of the present invention permits the assay for agonists and antagonists of the formation of the biologically active complex as well as therapeutic and diagnostic reagents based on the biologically active complex or interaction between the biologically active complex and a receptor, ligand or other molecule.
    Type: Grant
    Filed: October 6, 2000
    Date of Patent: March 20, 2007
    Assignee: Zenyth Operations Pty Ltd.
    Inventors: Andrew Nash, Kim Maree Jachno, Louis J. Fabri, Kate Reid, Perry F. Bartlett, Douglas J. Hilton, Yasuhiko Nakata, Masakazu Hasegawa
  • Generation of neural precursor cell lines
    Patent number: 5580777
    Abstract: A method for the in vitro production of lines of immortalized neural precursor cells, including cell lines having neuronal and/or glial cell characteristics, comprises the step of infecting neuroepithelium or neural crest cells with a retroviral vector carrying a member of the myc family of oncogenes.
    Type: Grant
    Filed: October 27, 1994
    Date of Patent: December 3, 1996
    Assignee: Amrad Corporation Limited
    Inventors: Ora Bernard, Perry F. Bartlett